Advertisement

Why Cardiff Oncology Stock Is Crashing Today

Why Cardiff Oncology Stock Is Crashing Today

Shares of Cardiff Oncology (NASDAQ: CRDF) were trading 19.8% lower as of 11:44 a.m. EST on Friday. The big drop came after the company presented data from a phase 1b/2 study of onvansertib in treating KRAS-mutated metastatic colorectal cancer (mCRC) at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium. Biotech stocks don't plunge when investors are happy with clinical trial updates.